- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02276599
A Prospective Investigation of Pleth Variability Index (PVI) as a Dynamic Parameter of Fluid Responsiveness in Children
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Hypovolemia is a frequent cause of circulatory failure in anesthetized and critically ill children. Fluid boluses are the first line of treatment aimed at optimizing stroke volume and ultimately improving oxygen delivery. A patient whose stroke volume significantly increases as a result of a fluid bolus is deemed 'fluid responsive'. Traditional parameters of circulatory status (e.g. blood pressure, heart rate, central venous pressure) have been shown to be ineffective at predicting fluid responsiveness. Dynamic parameters of fluid responsiveness, such as pulse pressure variation (PPV) and stroke volume variation (SVV), reflect hemodynamic changes secondary to intermittent positive pressure ventilation. These indices have proven to be superior to the traditional static measures of circulatory status in predicting fluid responsiveness. Furthermore, the use of these dynamic parameters in a goal-directed fashion has been shown to improve outcome in high risk, adult surgical patients. As such, there is increasing interest in using dynamic parameters to guide fluid resuscitation in mechanically ventilated infants and children. Unfortunately, there is a paucity of literature examining the validity of these dynamic parameters in children. The need for arterial vascular access, which is less common in small children, has also limited the ability to investigate these parameters. Recently, a non-invasive dynamic parameter has been developed examining the plethysmographic waveform from a pulse oximeter. The pleth variability index (PVI) represents the dynamic changes in hemodynamic performance that occur during the respiratory cycle. Studies of PVI in adults have shown it to be a reliable predictor of fluid responsiveness. However, conclusive data in children are lacking.
Hypothesis: This study is designed to investigate the ability of PVI to non-invasively predict fluid responsiveness in mechanically ventilated children. The hypothesis is that a higher PVI will predict significant stroke volume increases in response to a fluid bolus in mechanically ventilated children.
Methods: The study population will consist of 20 children undergoing cardiac catheterization who will have normal (non-shunted) physiology at the conclusion of the procedure, ages 1-12 years. All subjects will receive a PVI measurement as well as a stroke volume measurement via transthoracic echocardiography. Subsequent volume expansion will be achieved with an intravenous bolus of 10 mL/kg of isotonic crystalloid (normal saline) administered over 10 minutes. After completion of the bolus, an additional PVI measurement and stroke volume measurement will be obtained.
Significance: Hypovolemia is a significant cause of harm in anesthetized and critically ill infants and children. In order to successfully resuscitate these patients, we must gain a better understanding of how to optimize cardiac output and oxygen delivery. A non-invasive monitor which indicates stroke volume responsiveness has the potential to better guide fluid resuscitation and improve outcomes.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43205
- Nationwide Children's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Children undergoing cardiac catheterization who will have normal (non-shunted) physiology at the conclusion of the procedure.
Exclusion Criteria:
- Patients with additional congenital heart abnormalities, cardiac arrhythmias, ventricular dysfunction, and known pulmonary disease.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Cardiac catheterization
Patients with a diagnosis of atrial septal defect who are having a cardiac catheterization.
|
Fluid bolus of 0.9% normal saline 10 mL/kg over 10 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Pleth Variability Index
Time Frame: 10 minutes
|
Change in Pleth Variability Index following fluid bolus of 0.9% normal saline 10 mL/kg over 10 minutes, measured by Masimo Radical-7 monitor.
|
10 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Cardiac Output
Time Frame: 10 minutes
|
Change in cardiac output following fluid bolus of 0.9% normal saline 10 mL/kg over 10 minutes, measured by interventional radiologist during cardiac catheterization.
|
10 minutes
|
Change in Stroke Volume
Time Frame: 10 mins
|
Change in stroke volume following fluid bolus of 0.9% normal saline 10 mL/kg over 10 minutes, measured by echocardiogram.
|
10 mins
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Brian Schloss, MD, Nationwide Children's Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB14-00332
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atrial Septal Defect
-
Assiut UniversityWithdrawnASD2(Secundum Atrial Septal Defect)
-
W.L.Gore & AssociatesCompletedSeptal Defect, AtrialUnited States
-
Occlutech International ABCompletedSecundum Atrial Septal Defects
-
Asklepion Pharmaceuticals, LLCCompletedAtrial Septal Defect | Atrioventricular Septal Defect | Ventricular Septal DefectUnited States
-
Ayman khairy MohamedCompletedAtrial Septal Defect, Secundum TypeEgypt
-
Abbott Medical DevicesTerminatedAtrial Septal Defect SecundumUnited States
-
Nobles Medical Technologies II IncEnrolling by invitationForamen Ovale, Patent | Septal Defect, Atrial | Septal Defect, HeartUnited States, Italy
-
HeartStitch.ComUnknownForamen Ovale, Patent | Septal Defect, Atrial | Septal Defect, HeartUnited States
-
W.L.Gore & AssociatesCompleted
-
Abbott Medical DevicesRecruitingPFO - Patent Foramen Ovale | VSD - Muscular Ventricular Septal Defect | PIVSD - Post Infarct Muscular Ventricular Septal Defect | ASD - Atrial Septal DefectSpain, Germany, Poland, France, Italy, Netherlands, Switzerland
Clinical Trials on Volume expansion
-
Seoul National University HospitalCompletedFluid ResponsivenessKorea, Republic of
-
Seoul National University HospitalCompletedFluid ResponsivenessKorea, Republic of
-
Hallym University Kangnam Sacred Heart HospitalCompletedLaparoscopic SurgeryKorea, Republic of
-
Yonsei UniversityCompletedCoronary Artery Occlusive DiseaseKorea, Republic of
-
Montreal Heart InstituteCompletedLeft Ventricular Function Diastolic Dysfunction | Fluid ResponsivenessCanada
-
Poitiers University HospitalCompleted
-
University of MonastirCompletedAcute Circulatory FailureTunisia
-
Chinese PLA General HospitalUnknownFluid Therapy | Fluid Responsiveness | Stroke Volume Variation | Pulse Pressure VariationChina
-
Asan Medical CenterCompletedFluid Responsiveness | Modified Prone PositionKorea, Republic of
-
Hospices Civils de LyonCompleted